T 
TATA Health International Holdings 1255.HK · HKD
Consumer Discretionary · HKEX · 🇭🇰 Hong Kong
1.71
-6.56%
Close of 5 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in HKD, from our data supplier.
Revenue
HK$99.8m
FY2016FY2025
Net income
HK$13.3m
FY2016FY2025
Free cash flow
−HK$22.4m
FY2016FY2025
Shareholders' equity
−HK$54.4m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | HK$99.8m | HK$124.5m | HK$207.5m | HK$169.1m | HK$188.1m | HK$181.6m | HK$399.6m | HK$418.5m | HK$565.5m | HK$657.6m |
| Gross profit | HK$80.3m | HK$84.9m | HK$150.8m | HK$133.2m | HK$122.4m | HK$40.1m | HK$233.2m | HK$257.8m | HK$295.6m | HK$374.7m |
| Operating income | −HK$23.2m | −HK$54.9m | −HK$34.4m | HK$7.7m | −HK$77.6m | −HK$197.7m | −HK$75.9m | HK$963,321 | −HK$46.5m | −HK$39.4m |
| Net income | HK$13.3m | −HK$68.3m | −HK$32.3m | HK$11.2m | −HK$82.4m | −HK$202.3m | −HK$78.2m | HK$7.1m | −HK$50.8m | −HK$40.5m |
| Diluted earnings per share | 0.05 | -0.28 | -0.13 | 0.05 | -0.35 | -0.95 | -0.37 | 0.03 | -0.24 | -0.20 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | HK$91.1m | HK$135.2m | HK$182.1m | HK$205.8m | HK$206.8m | HK$188.7m | HK$373.5m | HK$406.6m | HK$392.3m | HK$483.8m |
| Cash and short-term investments | HK$17.9m | HK$23.0m | HK$40.0m | HK$39.3m | HK$55.0m | HK$56.7m | HK$54.7m | HK$33.7m | HK$28.4m | HK$30.7m |
| Total liabilities | HK$145.6m | HK$191.4m | HK$198.3m | HK$183.7m | HK$190.9m | HK$176.5m | HK$171.8m | HK$129.6m | HK$198.0m | HK$268.6m |
| Debt | HK$25.9m | HK$35.9m | HK$54.4m | HK$59.7m | HK$61.6m | HK$108.4m | HK$120.2m | HK$55.5m | HK$162.6m | HK$239.8m |
| Shareholders' equity | −HK$54.4m | −HK$64.4m | HK$1.7m | HK$39.3m | HK$26.9m | HK$11.8m | HK$187.8m | HK$256.8m | HK$194.3m | HK$215.2m |
| Shares outstanding | 243m | 243m | 243m | 243m | 232m | 214m | 214m | 214m | 212m | 200m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −HK$18.6m | HK$1.2m | HK$37.8m | HK$15.2m | −HK$5.7m | HK$298,115 | HK$23.0m | HK$25.9m | HK$80.3m | HK$11.1m |
| Capital spending | −HK$3.8m | −HK$4.8m | −HK$4.0m | −HK$1.0m | −HK$1.3m | −HK$3.6m | −HK$5.8m | −HK$2.0m | −HK$2.6m | −HK$6.2m |
| Free cash flow | −HK$22.4m | −HK$3.6m | HK$33.8m | HK$14.2m | −HK$7.0m | −HK$3.3m | HK$17.1m | HK$23.9m | HK$77.6m | HK$4.9m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | HK$47.3m | HK$57.7m | HK$42.1m | HK$52.1m | HK$72.3m | HK$103.4m | HK$121.7m | HK$94.8m |
| Gross profit | HK$31.0m | HK$45.4m | HK$34.8m | HK$29.6m | HK$55.4m | HK$65.5m | HK$99.6m | HK$71.8m |
| Operating income | −HK$16.9m | −HK$2.0m | −HK$21.2m | −HK$54.0m | −HK$830,000 | −HK$20.1m | −HK$16.7m | −HK$16.2m |
| Net income | −HK$290,000 | −HK$7.2m | HK$20.6m | −HK$63.2m | −HK$5.1m | −HK$20.0m | −HK$14.4m | −HK$12.3m |
| Diluted earnings per share | -0.00 | -0.03 | 0.08 | -0.26 | -0.02 | -0.08 | -0.06 | -0.05 |
| Cash from operations | — | −HK$3.0m | −HK$14.11bn | −HK$4.0m | — | — | −HK$16.0m | HK$14.0m |
| Capital spending | — | −HK$3.0m | — | −HK$4.0m | — | — | — | — |
| Free cash flow | — | −HK$6.0m | — | −HK$8.0m | — | — | — | — |
| Total assets | HK$97.4m | HK$91.1m | HK$122.8m | HK$135.2m | HK$175.9m | HK$182.1m | HK$218.9m | HK$205.8m |
| Cash and short-term investments | HK$10.4m | HK$17.9m | HK$22.4m | HK$23.0m | HK$38.1m | HK$61.2m | HK$20.9m | HK$39.3m |
| Debt | HK$31.8m | HK$25.9m | HK$35.5m | HK$35.9m | HK$51.2m | HK$29.8m | HK$68.8m | HK$59.7m |
| Shareholders' equity | −HK$55.0m | −HK$54.4m | −HK$48.9m | −HK$64.4m | −HK$2.0m | HK$1.7m | HK$26.5m | HK$39.3m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -16.1% | -11.3% | -17.2% |
| Operating income | — | -34.9% | 4.1% |
| Net income | 5.9% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 73.7% | 74.8% | 63.0% | 59.4% |
| Operating margin | -34.8% | -17.4% | -39.2% | -15.2% |
| Net margin | -24.5% | -12.7% | -37.2% | -14.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 23.6 | -1.1 | -2.4 | 12.3 | -2.9 | -1.2 | -3.9 | 17.9 | -3.5 | -4.4 |
| Price to sales | 3.2 | 0.6 | 0.4 | 0.8 | 1.3 | 1.3 | 0.8 | 0.3 | 0.3 | 0.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 18 May 2015.
| FY2015 | FY2014 | |
|---|---|---|
| Paid in the year | 0.023 | 0.04 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.